Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
These maps provide a common framework for discussing the therapeutic development process.
Review a list of all the innovative programs and initiatives that NCATS supports.
NCATS-supported researchers at Boston University found a strong link between the use of medications to treat opioid use disorder and a reduced risk of overdose death.
Investigators from the Scripps Translational Science Institute advance precision medicine to combat a dangerous heart condition through improved screening and diagnostic approaches.
NCATS has released two new funding opportunities to support research on rare diseases through the Rare Diseases Clinical Research Network.
Read about a new approach to stop cancer metastasis, advancing a rare disease gene editing treatment into clinical trials, CTSA Program community engagement assessments, and more.
With support from the Rare Diseases Clinical Research Network, scientists have developed a personalized approach to diagnosing and treating eosinophilic esophagitis.
Scientists use 3-D tissue chips to mimic human spinal cord development
RDCRN support helps enable potential gene-editing therapy to advance to clinical trials.
Christopher P. Austin, M.D.
View funded activities under the NCATS Clinical and Translational Science Awards Program. (PDF - 80KB)
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …